帝人(株)『Humanity, chemistry, and our 100 years : the Teijin story : 1918-2018』(2022.01)

目次は見出しの階層(編・章・節・項…など)ごとに絞り込んで見ることができます。

… 資料編に詳細な情報があります。

目次項目 ページ
HUMANITY, CHEMISTRY, AND OUR 100 YEARS / Jun Suzuki President and CEO,Representative Director of the Board 巻頭
Part 1 The Age of Chemical Fibers 1904-1967 〔1〕
Introduction Japan's First Artificial Silk Manufacturer 1904-1917 p2
Launching Viscose Research / Manufacturing Artificial Silk Using the Viscose Method / The Establishment of the Yonezawa Artificial Silk Yarn Manufacturing Plant p2
Chapter 1 The Birth of Teikoku Jinzo-Kenshi 1918-1932 p6
The Establishment of Teikoku Jinzo-Kenshi / Construction of the Hiroshima Plant / The Iwakuni Plant Comes On Line / Financial Panic and the Collapse of Suzuki Shoten / Expanding Rayon Output and the Start of Staple Fiber Production / The Yonezawa Plant Shuts Its Doors / Creating an Effective Sales Configuration / Operating Results (1918-1932) p6
Chapter 2 At the Forefront of the Rayon Industry 1933-1945 p14
1. Responding to Soaring Demand for Rayon and Expanding Production Capabilities p14
The Golden Era of Japan's Rayon Industry / Building the Mihara Plant / The Establishment of Daini Teikoku Jinken / Full-Scale Production of Rayon Staple Fiber and the Establishment of the Marifu Plant / Public Listing and the Teijin Incident p14
2. Increasingly Stringent Wartime Economic Controls p18
Wartime Company Restructurings / The Shift to Wartime Production / China Rayon and the Establishment of Teijin Aircraft Industry / The Deaths of Naokichi Kaneko and Itsuzo Hata p18
3. Overview of the Organization and Operating Results p20
Reorganization of the Company's Headquarters / Operating Results (1933-1945) p20
Chapter 3 The Recovery of the Rayon Business 1946-1953 p22
1. Postwar Recovery p22
The Atomic Bombing of Hiroshima / Restarting Production / The Dissolution of the Zaibatsu and Its Impact on Teikoku Jinzo-Kenshi / A New Salt Production Business and the Okunoshima Poison Gas Cleanup Operation / Shinzo Ohya Inaugurated as President / The Death of Seita Kumura / A New Headquarters Building / A Visit from the Emperor and the Launch of a New Company Song p22
2. Korean War-Related Special Procurement Demand and the Textiles Boom p28
From the Removal of Restrictions to Economic Prosperity / Production of High-Tenacity Rayon Filament / Building the Nagoya Plant and Bidding Farewell to the Hiroshima Plant / Operating a Woven Fabrics Plant / The Establishment of Teijin Shoji p28
3. Overview of the Organization and Operating Results p32
The Formation of Employee Unions / Teijin Scholarships / Operating Results (1946-1953) p32
Chapter 4 A Shift to Synthetic Fibers and the Expansion of Operations 1954-1967 p34
1. Structural Reforms in a Time of High Economic Growth p34
The Origins of the Japanese Economic Miracle / A Major Curtailment of Rayon Operations / Rayon Recession and a Voluntary Retirement Program / Shinzo Ohya Returns as President to Spearhead Restructuring / Formulating Long-Term Management Plans /Adopting a Divisional Structure / Enhancing R&D Capabilities / Relocation of Headquarters Functions to Tokyo and a New Name p34
2. Entering the Synthetic Fibers Business p39
Independent Acetate Research / Introducing Acetate Technology and Building the Matsuyama Plant / The Decline of Rayon and Research in the Area of Synthetic Fibers / Proprietary Synthetic Fibers Research / The In-House Invention of Teviron / Licensing In Polyester Technologies / Concluding a Licensing Agreement with ICI / Production of Tetoron Polyester Fibers Begins / Tetoron Marketing Launch / Expansion of Tetoron Production / Achieving Self-Sufficiency in DMT / Expansion into Aromatic Petrochemicals and Construction of the Tokuyama Plant / Acquisition of Nylon Technology / An Attempt to Commercialize Acrylic / Establishing an Overseas Presence / Fiber Processing and Finishing in Overseas Markets p39
3. Launching the Chemical Products Business p53
The Start of Polycarbonate Resin Production / Licensing In Polycarbonate Resin Technology from Bayer / Establishment of the Chemical Products Division / Entry into the Cellophane Business / The Beginnings of Teijin's PET Film Business p53
4. Overview of the Organization and Operating Results p58
Reform of the Personnel System / Operating Results (1954-1967) p58
Part 2 An Era of Diversification 1968-1990 〔61〕
Chapter 1 Diversifying Operations 1968-1976 p62
1. The End of Japan's Postwar Economic Miracle and the Diversification of Operations p62
U.S.-Japan Textile Negotiations and the Dollar Shock / The First Oil Shock / Establishing the Future Development Division / Aiming for Net Sales of 2 Trillion / Creating the Comprehensive Action Committee and Appointing Roving Ambassadors / A New Osaka Headquarters Building p62
2. Growth of the Tetoron Business and Withdrawal from the Rayon Business p66
Construction of the Ehime Plant / Expanding the Overseas Fibers Business / Launching Polyester Polymerization and Yarn Production Outside Japan / Launching Polyester Weaving and Dyeing Operations Overseas / Licensing Out Production Technologies and Exporting Plants / Sowing the Seeds for Diverse New Synthetic Fibers Businesses / Downstream Expansion of the Fibers Business / Withdrawal from the Rayon Business p66
3. Expansion of the Chemical Products Business p77
A New Business Configuration / Increasing Production of Panlite Polycarbonate Resin / Commercializing FR-PET and PBT Resin / Full-Scale Commercialization of PET Film and Construction of the Gifu Plant / Entering and Exiting the PEN Film Business / The Flooding of the Gifu Plant p77
4. Expanding into the Pharmaceuticals Business p81
Establishing the Medical & Pharmaceutical Industries Division / Exploratory Initiatives / Investing in Daisan Pharmaceuticals / Establishing and Swiftly Withdrawing from Alcon-Teijin / Partnership with Boehringer Ingelheim / Dialyzer Development Efforts p81
5. Promoting Diversification p85
Entering the Petroleum Development Business / Expanding into Food Products / Expanding into the Lifestyle Arena / Expanding into the Information Sector / Other Diversification Efforts p85
6. Overview of the Organization and Operating Results p92
Deployment of New Systems / Construction of the Fuji Institute of Education & Training / Establishing a Monument to the Birthplace of the Artificial Fibers Industry / Operating Results (1968-1976) / From Diversification to Liquidation p92
Chapter 2 A Change of Direction: From Expanding Operations to Growing New Businesses 1977-1990 p96
1. Deteriorating Results and a State of Emergency p96
From Endaka Recession to the Bubble Economy / A State of Emergency / Resolving to Implement a Radical Rationalization Plan / Reinstating a Function-Specific Divisional Configuration / The Death of Shinzo Ohya / Tomoo Tokusue Takes Control / A New Long-Term Management Plan and Efforts to Strengthen the Policy Board / Formulation of a Medium-Term Management Plan and a New Business Division Configuration / The Appointment of Sashiro Okamoto / Hiroshi Itagaki Takes Office / An Overall Reorganization and the Absorption of Teijin Acetate p96
2. The Reorganization of the Fibers Business p102
Withdrawal from Overseas Fibers Businesses / Consolidation and Integration of Domestic Fibers Businesses / The Debut of Milpa and the Shingosen Boom / The Growth of New High-Performance Synthetic Fibers p102
3. The Expansion of the Films and Plastics Business p107
Development of Polycarbonate Resin for CDs and the Rapid Advance of Sales / Entry into the Market for PET Resin for Bottles / Emphasis on Film for Magnetic Applications / Moving into the Floppy Disk Business / Reinforcing the Film Processing Business / Revival of the PEN Film Business p107
4. Steady Expansion of the Pharmaceuticals Business p112
Establishing and Absorbing Teijin Pharmaceutical / The Launch of Venilon: Teijin's First Unique Proprietary Drug / Launching Onealfa as the Next Proprietary Drug / Bringing In New Drugs from Boehringer Ingelheim / Creating a Pharmaceuticals Production Configuration / The Start of Outsourced Sales / The Search for Next-Generation Products / Promoting Advanced Research / Introducing Alendronate / Research in Structural Modification and New Dosage Forms / Licensing Out Technologies and Products to Overseas Companies / Expanding into the Dialyzer Business / Entry into the Clinical Laboratory Testing Field / Diversifying into Diagnostic Drugs p112
5. Inaugurating the Home Healthcare Business p125
Developing a Membrane Oxygen Concentrator / Authorization of HOT for NHI Coverage and the Creation of an Independent Business Model / Introducing an Adsorption-Type Oxygen Concentrator / Establishing a Proper Oxygen Concentrator Production Configuration p125
6. Expanding into the Petroleum-Related Equipment Business p128
Entering Oil Well Pipe-Related Businesses / Developing Anchors for Use in Civil Engineering and Construction / Spinning Off Headquarters Functions p128
7. Overview of the Organization and Operating Results p130
Extension of the Mandatory Retirement Age and Overhaul of the Personnel System / Operating Results (1977-1990) p130
Part 3 The Epoch of New Value Creation 1991-2018 〔133〕
Chapter 1 Building a Framework for Profitable Growth 1991-2000 p134
1. The Road to Revitalization p134
The Collapse of the Bubble and a Prolonged Economic Slump / Inaugurating of the Revitalization Project / Setting Forth the Corporate Philosophy and Implementing Revitalization Measures / A New Long-Term Management Plan p134
2. Toward Profitable Growth p137
A New Management Team Takes the Reins / The Launch of the Forward 2000 Medium-Term Management Plan / Improving the Efficiency of Head Office Functions and Delegating Authority / The Creation of a Chief Officer System p137
3. Promoting CSR p139
Governance Reform / A New Risk Management and Compliance Framework / Environmental Management Initiatives p139
4. The Resurgence of the Polyester Fibers Business p142
The Million-Tonne Vision / The Second Global Push for the Fibers Business / Spinning Off the Nylon Fibers Business p142
5. Growing the High-Performance Fibers Business p146
Advancing into Carbon Fibers /Adding Twaron to the Teijin Portfolio / Expanding the Technora Business / Diversifying into the Meta-Aramid Paper Business p146
6. Efforts to Strengthen Trading Company Capabilities p149
The Birth of N.I. Teijin Shoji / Developing a Fashion Brand Business p149
7. Globalization of the Plastics Business p151
Creating a Global Production Configuration for Polycarbonate Resin / An Expanded Global Resins Sales Network / Reinforcing Resin-Related R&D / Restructuring the PBT and FR-PET Businesses p151
8. Evolution into a Global Player in the Films Business p153
Establishing Joint Ventures with DuPont / Expanding Global PET Films Joint Ventures / Reinforcing the Operating Foundations of the Films Business / Responding to Demand for PET Film for New Applications / The Growth of the PEN Film Business / Commercializing Film for LCDs p153
9. Establishing a Direct Sales Configuration for Pharmaceuticals p158
Setting Up Direct Sales Nationwide / Launching Bonalfa: Teijin's First New Proprietary Drug in 13 Years p158
10. R&D and the Discovery of New Drugs p159
Research in the Area of Small Molecule Drug Discovery / The Development of TMX-67 / Overhauling the Research Framework / Creating a New Drug Development Configuration / A Pipeline Strategy Integrating In-House Development and Licensed-In Products / Providing Added Value: Expanded Indications and New Dosage Forms / Licensing Out Proprietary Drugs: Laying the Groundwork for the Globalization of TMX-67 p159
11. Withdrawal from Peripheral Businesses p162
12. Entering New Areas in the Home Healthcare Field p163
An Expanded Sales Configuration / New Home Healthcare Equipment / Patient Support in the Aftermath of the Great Hanshin Earthquake / A New Challenge: The Personal Dialysis Market / Strengthening the Research Configuration and Business Development Efforts p163
13. The Birth of Infocom p167
Teijin Systems Technology: The Synthetic Fibers Industry's First Software Development and Sales Company / Infocom: Nissho lwai's Systems Development and Services Subsidiary / The Merger of Teijin Systems Technology and lnfocom p167
14. Chlorofluorocarbon Alternatives, Composite Materials and Recording Media p168
The Challenge of Eliminating Chlorofluorocarbons / Forays into Composite Materials / Exploring Opportunities in the Recording Media Business p168
15. Overview of the Organization and Operating Results p171
The Revision of Key Systems / Operating Results (1991-2000) / Realignment of Financing Subsidiaries p171
Chapter 2 Advancing Group and Global Management 2001-2007 p174
1. Strengthening Group Management p174
Japan's Longest Post-War Economic Boom /A New Management Team / Adopting a Holding Company System / Rebuilding and Augmenting Overall Profitability / Promoting Business Reforms to Achieve Innovative Growth / Putting Down Firmer Roots in Promising Markets / Reinforcing R&D Capabilities / Building a Stronger Corporate Brand / Efficient Asset Management through Reduction and Effective Use p174
2. Adding Depth to CSR Initiatives p180
Building a Stronger CSR Framework / Encouraging Environmental Management / Launch of Chemical Recycling p180
3. Results Growth Driven by High-Performance Fibers p184
Expanding the Aramid Fibers Business / A New Brand and Expanded Global Bases for Carbon Fibers / Emergence of Carbon Fiber Cartels p184
4. Rebuilding the General-Purpose Fibers Business p186
Reforming the Polyester Fibers for Apparel Business / Strategic Moves by Teijin Fibers / Withdrawal from Unprofitable Fibers Businesses / Transforming N.I. Teijin Shoji into a Wholly Owned Subsidiary p186
5. Advancing the Resins Business Worldwide p190
Polycarbonate Resin Production in the PRC / Enhancing Molding Technologies / Carbon Monoxide Leak and Efforts to Enhance Workplace Safety / Expanding Resin Production and Sales p190
6. Bolstering the PET and PEN Films Businesses p192
Reinforcing Films Production and Sales Capabilities p192
7. Launch of Bonalon and Sustained Growth in the Pharmaceuticals Business p194
Proposal for Business Integration with Kyorin Pharmaceutical / Bonalon: Unveiling a New Major Drug p194
8. Promoting R&D in the Area of Pharmaceuticals p195
A New Emphasis on Clinical Development / Capitalizing On Licensing-In Arrangements to Introduce New Drugs / Providing Value by Expanding Indications and Adding New Dosage Forms / Cultivating Overseas Markets p195
9. Taking On New Challenges: Broadening the New Home Healthcare Business p198
Expanding the HOT Business by Accepting Consignment Orders and Making Key Acquisitions / Recall of a Core Device p198
10. Expanding the Scope of the IT Business p200
Launching GRANDIT / Introducing E-Book Distribution Services / Flagging Results and a Swift Recovery p200
11. Diversification into Battery Materials and Environmental Solutions p202
Entering the Market for Battery Materials / Expanding Environmental Businesses p202
12. Overview of the Organization and Operating Results p204
Amendments to the Personnel System / Operating Results (2001-2007)/Reform Measures in Noncore Businesses / Delisting and the Introduction of Hostile Takeover Defense Measures /A New Group Song p204
Chapter 3 Structural Reforms and Portfolio Transformation 2008-2018 p208
1. Embarking on a New Growth Trajectory p208
A Global Economic Slump / Shigeo Ohyagi Becomes President / A Second State of Emergency / Formulating Basic Management Policies for the Teijin Group / A New Medium- to Long-Term Management Vision: CHANGE for 2016 / Organizational Changes to Facilitate a Solutions-Oriented Business Model / Jun Suzuki Takes Over as President / Revising CHANGE for 2016 / ALWAYS EVOLVING: Toward Realization of the Teijin Group's Long-Term Vision / An Updated Corporate Organization Centered on Materials and Healthcare Businesses p208
2. Reinforcing CSR p215
An Updated CSR Policy and the Promotion of Related Initiatives / Scaling Back the Recycling Business / Responding to the Great East Japan Earthquake / Relocating the Tokyo and Osaka Head Offices p215
3. Polyester Fibers: Shifting Expansion Strategies p218
Downsizing the Polyester Fibers Business / Exiting the Polyester Raw Materials Business / The Dissolution of Teijin Fibers / Establishing Teijin Frontier / Demise of the Expansion Strategy for General-Purpose Polyester Fibers p218
4. High-Performance Fibers: Reinforcing the Aramid Fibers and Carbon Fibers Businesses p221
Further Strengthening the Aramid Fibers Business / From Struggles to Renewed Expansion in the Carbon Fibers Business / Evolution of Downstream Carbon Fibers Businesses / Diversifying into Materials for Aerospace Applications / Renaming Teijin Group Carbon Fibers Companies p221
5. Plastics: Realigning Businesses and Extending Downstream Solutions p224
Shifting to a Solutions-Oriented Business Model / Developing Downstream Polycarbonate Resins Businesses / Bolstering Sales of Polycarbonate Resin for LCDs and Touchscreens / Revamping the Overseas Polycarbonate Resin Production Configuration / Withdrawal from Fumigants, PET Resin for Beverage Bottles and PBT / Diversifying into New High-Performance Resins Businesses p224
6. Films: A Shift in Focus to Asia p227
Responding to Growing Demand for PET Film for New Applications / Developing New Technologies and Applications to Create New Markets / Relocating Production to Asia p227
7. Pharmaceuticals: The Launch and Global Deployment of Febuxostat p229
The Debut of Feburic / Global Sales of Febuxostat p229
8. Accelerating Pharmaceuticals R&D p231
Drug Development Efforts Centered on Early-Stage Joint Research / Licensing In New Drugs / Adding Value by Expanding Indications and Dosage Forms p231
9. Home Healthcare: Globalization and the Promotion of New Businesses p234
Launching Home Healthcare Services Overseas / Establishing a Medical Device Production Configuration in the PRC / Cultivating Domestic Demand in the Area of Respiratory Disease / New Directions in Home Healthcare p234
10. IT: The Growth of Infocom p240
IT Solutions: A Renewed Focus on Healthcare / Digital Entertainment: Augmenting and Strengthening E-comic Distribution Services / Strategies for Creating New IT Businesses / Terminating Shin-Yokohama Data Center Services / An Increased Stake in Infocom p240
11. New Businesses: Emphasis on the Materials and Healthcare Sectors p241
Adding Depth to Composite Materials / Developing New Healthcare Businesses / Commercializing LIB Separators / Launch of the High-Performance MIRAIM Membrane / Efforts to Commercialize Products in Overlapping Areas p241
12. Overview of the Organization and Operating Results p247
Revisions to Key Human Resources Systems / Operating Results (2008-2018) p247
Chapter 4 The Road to Future Value Creation: Ceaseless Evolution and Ambition 2018- p252
Creating Future Value / Stepping Up Growth and Transformation Strategies / Ceaseless Evolution and Ambition: The Next 100 Years p252
Appendix 〔255〕
1. Our Philosophy p257
Corporate Philosophy / Brand Statement / Long-term Vision / Code of Conduct p257
2. Articles of Incorporation p260
3. 100 Years of Leadership: Teijin's Presidents p263
4. Corporate Governance Guide p264
5. CSR p268
CSR Basic Policy / Teijin Group Global Environmental Charter / Teijin Group Human Rights Policy p268
Editorial Notes p270
索引リスト
PAGE TOP